Published in Virchows Arch on February 01, 2002
Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study. Virchows Arch (2005) 2.76
Gastric-type well-differentiated adenocarcinoma and pyloric gland adenoma of the stomach. Gastric Cancer (2006) 1.26
Intraductal neoplasm of the intrahepatic bile duct: clinicopathological study of 24 cases. World J Gastroenterol (2012) 1.12
Pyloric gland adenoma arising in Barrett's esophagus with mucin immunohistochemical and molecular cytogenetic evaluation. Virchows Arch (2005) 1.01
Adenoma with gastric differentiation (so-called pyloric gland adenoma) in a heterotopic gastric corpus mucosa in the rectum. Virchows Arch (2005) 0.98
Immunohistochemical analysis of pyloric gland adenomas using a series of Mucin 2, Mucin 5AC, Mucin 6, CD10, Ki67 and p53. Virchows Arch (2010) 0.94
Intraductal tubular adenomas (pyloric gland-type) of the pancreas: clinicopathologic features are similar to gastric-type intraductal papillary mucinous neoplasms and different from intraductal tubulopapillary neoplasms. Diagn Pathol (2014) 0.82
[Intraductal neoplasms of the pancreas: cystic and common]. Pathologe (2005) 0.81
[Tubular adenoma of the stomach with special reference to the Japanese criteria and pyloric gland adenoma]. Pathologe (2010) 0.77
A Case Report of Intraductal Papillary-Mucinous Neoplasm of the Pancreas Showing Morphologic Transformation during Followup Periods. J Oncol (2009) 0.75
Regarding the paper by Vieth et al. Virchows Archiv 442/4:317-321. Virchows Arch (2003) 0.75
Pyloric gland adenoma: a case report. Case Rep Gastroenterol (2013) 0.75
Pyloric gland adenoma of the cystic duct with malignant transformation: report of a case with a review of the literature. BMC Cancer (2012) 0.75
Age-related methylation of tumor suppressor and tumor-related genes: an analysis of autopsy samples. Oncogene (2003) 1.59
Inhibition of NFkappaB increases the efficacy of cisplatin in in vitro and in vivo ovarian cancer models. J Biol Chem (2004) 1.50
Promoter methylation status of E-cadherin, hMLH1, and p16 genes in nonneoplastic gastric epithelia. Am J Pathol (2002) 1.48
Expression of hepatocyte nuclear factor-1beta (HNF-1beta) in clear cell tumors and endometriosis of the ovary. Mod Pathol (2006) 1.47
Promoter hypermethylation of tumor suppressor and tumor-related genes in non-small cell lung cancers. Cancer Sci (2003) 1.38
Multiple tumor suppressor genes are increasingly methylated with age in non-neoplastic gastric epithelia. Cancer Sci (2006) 1.33
Promoter hypermethylation of RASSF1A and RUNX3 genes as an independent prognostic prediction marker in surgically resected non-small cell lung cancers. Lung Cancer (2007) 1.25
Inhibition of phosphatidylinositol 3-kinase increases efficacy of cisplatin in in vivo ovarian cancer models. Endocrinology (2006) 1.25
Promoter methylation status of DAP-kinase and RUNX3 genes in neoplastic and non-neoplastic gastric epithelia. Cancer Sci (2003) 1.11
Carcinosarcomas (malignant mullerian mixed tumors) of the uterus and ovary: a genetic study with special reference to histogenesis. Int J Gynecol Pathol (2003) 1.08
Primary carcinoid tumor of the testis: Immunohistochemical, ultrastructural and FISH analysis with review of the literature. Pathol Int (2003) 1.07
Hepatocyte nuclear factor-1beta(HNF-1beta) in human urogenital organs: its expression and role in embryogenesis and tumorigenesis. Histol Histopathol (2009) 1.06
Inhibition of inhibitor of nuclear factor-kappaB phosphorylation increases the efficacy of paclitaxel in in vitro and in vivo ovarian cancer models. Clin Cancer Res (2004) 1.06
Re-expression of miR-199a suppresses renal cancer cell proliferation and survival by targeting GSK-3β. Cancer Lett (2011) 1.05
Spreading of methylation within RUNX3 CpG island in gastric cancer. Cancer Sci (2006) 1.02
Hypermethylation of the TSLC1 gene promoter in primary gastric cancers and gastric cancer cell lines. Jpn J Cancer Res (2002) 1.01
The enhancer of zeste homolog 2 (EZH2), a potential therapeutic target, is regulated by miR-101 in renal cancer cells. Biochem Biophys Res Commun (2012) 1.01
Glycogen synthase kinase-3beta: a prognostic marker and a potential therapeutic target in human bladder cancer. Clin Cancer Res (2010) 1.00
Hypermethylation of the RUNX3 gene promoter in testicular yolk sac tumor of infants. Am J Pathol (2003) 0.98
A case of perineal malignant melanoma successfully treated with electrochemotherapy. Melanoma Res (2005) 0.98
Analysis of genetic and epigenetic alterations of the PTEN gene in gastric cancer. Virchows Arch (2002) 0.96
Detection of HPV-DNA, p53 alterations, and methylation in penile squamous cell carcinoma in Japanese men. Pathol Int (2008) 0.94
Inverse correlation between EGFR mutation and FHIT, RASSF1A and RUNX3 methylation in lung adenocarcinoma: relation with smoking status. Anticancer Res (2011) 0.93
Demethylation of the synuclein gamma gene CpG island in primary gastric cancers and gastric cancer cell lines. Clin Cancer Res (2004) 0.90
Clear cell carcinoma arising in a cesarean section scar. Report of a case with fine needle aspiration cytology. Acta Cytol (2003) 0.90
Hypomethylation of hepatocyte nuclear factor-1beta (HNF-1beta) CpG island in clear cell carcinoma of the ovary. Virchows Arch (2007) 0.90
Histogenesis of hepatoid adenocarcinoma of the stomach: molecular evidence of identical origin with coexistent tubular adenocarcinoma. Int J Cancer (2003) 0.90
Hypermethylation of Chfr and hMLH1 in gastric noninvasive and early invasive neoplasias. Virchows Arch (2004) 0.88
Primary strumal carcinoid tumor of the ovary with multiple bone and breast metastases. J Obstet Gynaecol Res (2010) 0.88
Pyloric gland metaplasia/differentiation in multiple organ systems in a patient with Peutz-Jegher's syndrome. Pathol Int (2011) 0.87
Frequent epigenetic silencing of the p16 gene in non-small cell lung cancers of tobacco smokers. Jpn J Cancer Res (2002) 0.87
MAGE expressions mediated by demethylation of MAGE promoters induce progression of non-small cell lung cancer. Anticancer Res (2011) 0.87
Quantitative assessment of RUNX3 methylation in neoplastic and non-neoplastic gastric epithelia using a DNA microarray. Pathol Int (2006) 0.86
E-cadherin expression in follicular carcinoma of the thyroid. Pathol Int (2002) 0.85
Quantitative assessment of gene methylation in neoplastic and non-neoplastic gastric epithelia using methylation-specific DNA microarray. Pathol Int (2009) 0.85
Advanced malignant rhabdoid tumor of the ovary effectively responding to chemotherapy: a case report and review of the literature. Gynecol Oncol (2007) 0.85
Genetic analysis of cutaneous squamous cell carcinomas arising from different areas. Pathol Int (2003) 0.85
Promoter hypermethylation of DAP-kinase is associated with poor survival in primary biliary tract carcinoma patients. Cancer Sci (2004) 0.84
Frequent epigenetic silencing of the FHIT gene in penile squamous cell carcinomas. Virchows Arch (2008) 0.84
Small cell neuroendocrine carcinomas of the uterine cervix: a histological, immunohistochemical, and molecular genetic study. Int J Gynecol Pathol (2004) 0.84
Expression of hepatocyte nuclear factor-1beta in human urogenital tract during the embryonic stage. Anal Quant Cytol Histol (2009) 0.83
Immunocytochemistry for hepatocyte nuclear factor-1beta (HNF-1beta): a marker for ovarian clear cell carcinoma. Diagn Cytopathol (2007) 0.82
Involvement of adenomatous polyposis coli (APC) gene in testicular yolk sac tumor of infants. Hum Pathol (2005) 0.81
Methylation status of EXT1 and EXT2 promoters and two mutations of EXT2 in chondrosarcoma. Cancer Genet Cytogenet (2005) 0.81
Mucin expression in nonneoplastic and neoplastic glandular epithelia of the uterine cervix. Int J Gynecol Pathol (2003) 0.81
Ovarian Sertoli-Leydig cell tumor with heterologous gastrointestinal epithelium as a source of alpha-fetoprotein: a case report. J Obstet Gynaecol Res (2008) 0.81
Proteomics identified nuclear N-myc downstream-regulated gene 1 as a prognostic tissue biomarker candidate in renal cell carcinoma. Biochim Biophys Acta (2013) 0.80
Microsatellite instability in esophageal squamous cell carcinoma is not associated with hMLH1 promoter hypermethylation. Pathol Int (2003) 0.80
RUNX2 expression in developing human bones and various bone tumors. Pathol Int (2011) 0.80
Glassy cell carcinoma of the uterine cervix: histochemical, immunohistochemical, and molecular genetic observations. Int J Gynecol Pathol (2002) 0.79
Ovarian carcinoid exhibiting double function. Pathol Int (2003) 0.79
Expression of a transcription factor, SOX9, in Sertoli-stromal cell tumors of the ovary. Int J Gynecol Pathol (2004) 0.79
Expression of tumor suppressor and tumor-related proteins in differentiated carcinoma, undifferentiated carcinoma with tubular component and pure undifferentiated carcinoma of the stomach. Jpn J Clin Oncol (2005) 0.78
Endometrioid adenocarcinoma with a functioning stroma. J Obstet Gynaecol Res (2007) 0.78
Identifying prognostic factors in Japanese women with pseudomyxoma peritonei: a retrospective clinico-pathological study of the Tohoku Gynecologic Cancer Unit. Tohoku J Exp Med (2011) 0.78
Performance of p16INK4a/Ki-67 immunocytochemistry for identifying CIN2+ in atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesion specimens: a Japanese Gynecologic Oncology Group study. Int J Clin Oncol (2014) 0.77
KIT expression in normal and neoplastic renal tissues: immunohistochemical and molecular genetic analysis. Pathol Int (2005) 0.77
Relation between laminin-5 gamma 2 chain and cell surface metalloproteinase MT1-MMP in clear cell carcinoma of the ovary. Int J Gynecol Pathol (2009) 0.77
The Akt and ERK activation by platinum-based chemotherapy in ovarian cancer is associated with favorable patient outcome. Anticancer Res (2009) 0.77
Primary mucinous adenocarcinoma of the vagina: possibility of differentiating from metastatic adenocarcinomas. Pathol Int (2005) 0.77
Molecular and cellular phenotypic profiles of gastric noninvasive neoplasia. Lab Invest (2002) 0.76
Complete remission of ovarian small cell carcinoma treated with irinotecan and cisplatin: a case report. Anticancer Res (2007) 0.76
Alternate mucoid and hyalinized stroma in clear cell carcinoma of the ovary: manifestation of serial stromal remodeling. Mod Pathol (2010) 0.76
Ascitic fluid cytology of a malignant mixed Müllerian tumor of the peritoneum: a report of two cases with special reference to p53 status. Diagn Cytopathol (2009) 0.76
Hyalinized stroma in clear cell carcinoma of the ovary: how is it formed? Hum Pathol (2012) 0.75
Parathyroid carcinoma with anaplastic feature: association of a p53 gene mutation with anaplastic transformation. Pathol Int (2009) 0.75
Characteristic features of ovarian borderline tumors with invasive implant. Arch Gynecol Obstet (2005) 0.75
Absence of Bcl-2 expression favors response to the short-term administration of diethylstilbestrol diphosphate in prostate Cancer. Prostate (2006) 0.75
Ductal adenoma of the breast with chondromyxoid change. Pathol Int (2002) 0.75
Clonal expansion of multiple pulmonary leiomyomatous hamartoma: 12-year follow-up. Pathol Int (2009) 0.75
Pulmonary localized AA type amyloidosis with cyst-like structures and marginal zone B-cell lymphoma of the MALT type coexisting independently in the left upper lung. Intern Med (2008) 0.75
[An autopsy case of periampullary carcinoid with amyloid stroma and type 1 neurofibromatosis]. Nihon Shokakibyo Gakkai Zasshi (2009) 0.75
Spherule-like acellular stroma in clear cell carcinoma of the ovary: its utility in frozen section diagnosis. Histopathology (2011) 0.75
Characteristics of vulvar squamous cell carcinoma in Japanese women. Pathol Int (2007) 0.75
[A case of tubercular papillitis of Vater]. Nihon Shokakibyo Gakkai Zasshi (2010) 0.75